Company / Current Assets per Share
RAPT Therapeutics, Inc. Current Assets per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.77
FY2024
5-year range
$4.22 / $7.77
FY2020-FY2024
Trend
+36.8%
vs FY2023
Sector context
#118 of 208
Health Care
What the data says
At $5.77, RAPT Therapeutics, Inc.'s current assets per share ranks #118 of 208 in the Health Care sector. Current Assets per Share has fluctuated over the past 7 years, ranging from $4.22 in FY2023 to $104.55 in FY2018.
Based on SEC 10-K filings.
5.77 in FY2024 with a 5-year CAGR of -20.8%.
Declined from $7.77 to $5.77 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.4%
- 5-Year CAGR
- -20.8%
- 10-Year CAGR
- -
Sector benchmark
#118 of 208 in Health CareTop 57% of 208This company $5.77 Sector average $186.87
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 36.8% year-over-year.
- Ranks #118 out of 208 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.77 | +36.8% |
| FY2023 | $4.22 | -45.7% |
| FY2022 | $7.77 | +10.2% |
| FY2021 | $7.05 | +47.1% |
| FY2020 | $4.79 | -74.1% |
| FY2019 | $18.52 | -82.3% |
| FY2018 | $104.55 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026